These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex. Yoshida F, Suzuki T, Kashiwai A, Furuya T, Konishi J, Ogawa S. Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864 [Abstract] [Full Text] [Related]
12. [The use of sugammadex in a patient with myasthenia gravis]. Challan Belval A, Tramoni G, Vedrinne JM, Olagne E, Vigneron M. Ann Fr Anesth Reanim; 2012 Jun; 31(6):569-70. PubMed ID: 22677058 [No Abstract] [Full Text] [Related]
14. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial. Czarnetzki C, Tassonyi E, Lysakowski C, Elia N, Tramèr MR. Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361 [Abstract] [Full Text] [Related]
16. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex. de Boer HD, van Egmond J, Driessen JJ, Booij LH. Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852 [Abstract] [Full Text] [Related]
17. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Rex C, Wagner S, Spies C, Scholz J, Rietbergen H, Heeringa M, Wulf H. Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873 [Abstract] [Full Text] [Related]